Sudoscan Heads to Athens for the 36th NEUROdiab Annual Meeting

From 24 to 27 September 2026, Sudoscan will join specialists from around the world at the 36th Annual Meeting of the Diabetic Neuropathy Study Group. This year’s meeting will be held at the Royal Olympic Hotel in Athens, Greece.

As a major international gathering dedicated to diabetic neuropathy, NEUROdiab 2026 will offer a valuable opportunity to discover the latest research, exchange clinical perspectives and discuss evolving approaches to the understanding and management of the condition.

A Leading Scientific Forum for Diabetic Neuropathy

For the past 35 years, NEUROdiab has brought together specialists in basic and clinical science, while encouraging collaboration between leading experts and young researchers.

The 2026 scientific program will feature original research presentations, invited lectures and symposia covering a broad range of topics in diabetic neuropathy.

Discussions will address translational science, emerging risk factors, the natural history of the condition and the application of artificial intelligence. Other key subjects will include pain phenotyping, therapeutic advances, electrical stimulation, unexplored areas of autonomic control and brain involvement in diabetes.

Sudoscan: Supporting the Assessment of Sudomotor Function

At NEUROdiab 2026, Sudoscan will highlight the value of sudomotor function assessment in the evaluation and monitoring of peripheral autonomic neuropathies.

Sudoscan is a fast and non-invasive medical device that measures Electrochemical Skin Conductance through the palms of the hands and soles of the feet.

The painless and operator-independent test takes less than three minutes and provides immediate, quantitative and reproducible results. Sudoscan can support healthcare professionals in identifying and following peripheral autonomic dysfunction, particularly in patients with diabetes or conditions affecting small nerve fibers.

Its ease of use allows the technology to be integrated into clinical practice, research protocols and longitudinal patient follow-up.

Connect with the Sudoscan Team in Athens

Healthcare professionals and researchers attending NEUROdiab 2026 will have the opportunity to meet the Sudoscan team and learn more about the clinical and research applications of sudomotor testing.

Attendees will be able to discuss how Sudoscan can contribute to the assessment and monitoring of peripheral autonomic neuropathies and explore how the technology could be incorporated into their own clinical or research workflows.

We look forward to connecting with the international diabetic neuropathy community at the Royal Olympic Hotel in Athens from 24 to 27 September 2026.

For registration, the scientific program and further information, please visit the official NEUROdiab 2026 website.